- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02311738
Exercise and Genes in Obese (EGO) (EGO)
The Effect of Exercise and Genes on Energy Expenditure, Appetite and Quality of Life in Morbidly Obese Patients
Regular exercise has several positive health effects including increased physical fitness and muscle mass. It is well known that increased muscle mass is associated with increased resting energy expenditure which may facilitate weight loss and maintenance. Previous studies have, however, failed to show any consistent association between the intensity of physical exercise and energy expenditure, or relate the variance in these adaptations to genetic variability. Whether high-intensity exercise (HIE) is associated with improved health related quality of life in severely obese patients remains unknown.
This PhD-project is based on a planned randomised controlled study including 50 or more treatment seeking morbidly obese patients who will be randomised to either a 24 week moderate-intensity exercise (MIE) programme or a 24 week high-intensity exercise (HIE) programme. The investigators main hypothesis is that patients randomised to the HIE-program will achieve higher energy expenditure during rest and physical activity after treatment than those allocated to the MIE-programme. In addition, the investigators hypothesise that the HIE-group will achieve a better health related quality of life than the MIE-group after treatment. The investigators also hypothesize that inter-individual variability in adaptation to the two training regimens may be due to genetic factors. If the investigators hypotheses are confirmed, this project might have beneficial clinical implications for future obesity treatment strategies.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bø, Norway, 3800
- Telemark University College
-
Kristiansand, Norway, 4630
- University in Agder
-
Trondheim, Norway, 7491
- Norges Teknisk-naturvitenskapelig Universitet
-
Tønsberg, Norway, 3103
- Vestfold Hospital trust
-
-
Raveien
-
Horten, Raveien, Norway, 3184
- Vestfold University College
-
-
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Treatment seeking weight stable morbidly obese patients (BMI ≥ 40 kg/m2 or BMI 35 to 39.9 kg/m2 with ≥ 1 co morbidity) attending the outpatient Obesity Center, Vestfold Hospital Trust, will be informed about this RCT .
Exclusion Criteria:
- Uncompensated heart failure
- Recent myocardial infarction or stroke (<½ years)
- Severe arrhythmia or heart failure
- Unstable angina pectoris
- Renal failure
- Pregnancy
- Severe eating disorders
- Active substance abuse
- Being on a diet
- Taking medication known to affect appetite or metabolism (including thyroxin).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High intensity training group
HIE will consist of the following:
|
High intensity training group describes the group performing high intensity exercise intervention.
Moderate intensity training group describes the the group performing moderate exercise intervention
Other Names:
|
Experimental: Moderate intensity training group
MIE will consist of the following:
|
High intensity training group describes the group performing high intensity exercise intervention.
Moderate intensity training group describes the the group performing moderate exercise intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Energy expenditure during physical activity
Time Frame: 0, 8, 12 and 24 weeks
|
Energy expenditure (EE) during volitional activity will be measured with ergo-spirometry tests one week before the exercise intervention period starts, and repeated after each exercise period.
Increasing the aerobic work capacity is supposed to give the same proportional increase in energy expenditure at any given maximal intensity.
|
0, 8, 12 and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resting metabolic rate
Time Frame: 0, 8, 12 and 24 weeks
|
Resting metabolic rate will be measured with ergo-spirometry test one week before the exercise intervention period starts, and repeated after each exercise period.
Increasing the aerobic work capacity is supposed to give increased resting metabolic rate.
|
0, 8, 12 and 24 weeks
|
Cardiorespiratory fitness
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on cardiorespiratory fitness and will be measured with ergo-spirometry test
|
0, 8, 12 and 24 weeks
|
Body mass index
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on weight change and will be calculated as weight in kilograms divided by height in meters squared
|
0, 8, 12 and 24 weeks
|
Waist circumference
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on waist circumference and will be measured midway between the bottom edge of the lower rib and upper iliac crest in the horizontal plane.
|
0, 8, 12 and 24 weeks
|
Fat mass and fat free mass
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on body composition and will be measured with the bioelectrical impedance analyser Tanita BC-418
|
0, 8, 12 and 24 weeks
|
Appetite control
Time Frame: 0,12 and 24 weeks
|
Patient self-appraisal of hunger and fullness will be assessed during fasting and after a standardised breakfast every 30 minutes (for a period of 3hours) using visual analogue scales.
|
0,12 and 24 weeks
|
Genetic susceptibility
Time Frame: 0, 8, 12 and 24 weeks
|
We hypothesize that inter-individual variability in adaptation/response to the two training regimens may also be due to genetic factors.
We have designed a gene panel consisting of recognized and previously reported risk genes/variants with flanking sequences relevant for exercise (VO2max), participation in physical activity, obesity, diabetes, asthma and obesity related sub-phenotypes.
The panel covers 1.2 Mb and includes 299 genes (exons with exon-intron junctions) and 1468 intronic and intergenic SNPs.
Next-generation sequencing will be performed using a gene panel of selected genes/genetic regions by Illumina Nextera technology.
The method involves enzymatic fragmentation of DNA and probe-based enrichment.
The samples will be sequenced (paired-end, 2x100 bp) on a HiScanSQ.
All wet lab methods (with other gene panels) are ISO15189 certified and in routine use at Unit for Medical Genetics at Telemark Hospital.
|
0, 8, 12 and 24 weeks
|
Short form health survey (RAND-36)
Time Frame: 0,12 and 24 weeks
|
RAND-36 is a 36-item measure of generic HRQOL consisting of eight additive subscales (Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health) and two summary scores each based on four subscales (Physical Component Summary and Mental Component Summary).
Scores on all subscales range from 0 to 100.
Summary-scores will be norm-based, with mean (SD) 50 (10).
Higher scores on all scales represent better HRQOL.
|
0,12 and 24 weeks
|
Impact on Weight Questionnaire (IWQOL-Lite)
Time Frame: 0,12 and 24 weeks
|
IWQOL-Lite is a 36-item measure of generic HRQOL consisting of eight additive subscales (Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health) and two summary scores each based on four subscales (Physical Component Summary and Mental Component Summary).
Scores on all subscales range from 0 to 100.
Summary-scores will be norm-based, with mean (SD) 50 (10).
Higher scores on all scales represent better HRQOL.
|
0,12 and 24 weeks
|
Weight-Related Symptom Measure (WRSM)
Time Frame: 0,12 and 24 weeks
|
WRSM is a 20-item measure for the presence and distress of 20 weight-related symptoms.
The distress scores of the symptoms are reported on a six-point likert scale.
Two summary scores are calculated; an additive score of presence of symptoms ranging from 1 to 20 and a symptom distress score for all symptoms.
Symptom distress scores range from 0 to 100, with higher scores indicating a higher or worse total symptom distress.
|
0,12 and 24 weeks
|
Power of Food scale (PFS)
Time Frame: 0,12 and 24 weeks
|
PFS assess both the psychological impact and respondent's responsiveness to a food-abundant environment.
This is a 15-item scale whose items pertain to three situations: food being readily available in the environment but not physically present, food is physically present, but not tasted, and food is first tasted but not already consumed.
The three subscales is scored 0-100 with higher scores indicating greater eating problems.
|
0,12 and 24 weeks
|
Binge Eating Scale (BES)
Time Frame: 0,12 and 24 weeks
|
BES comprise 16 items assessing binge eating problems.
Additive scores range between 0-46, with higher scores indicating greater problems.
Cut-off scores have been established to determine binge severity, with "severe" represented by scores > 27, "moderate" by scores 18-26, and "mild-none" by scores < 17.
|
0,12 and 24 weeks
|
Three Factor Eating Questionnaire (TFEQ -R21)
Time Frame: 0,12 and 24 weeks
|
TFEQ -R21 is a 21-item questionnaire covering eating behavior domains: the cognitive restraint scale (6 items) assesses control over food intake and influence over body weight and body shape; the emotional eating scale (6 items) measures the propensity to overeat in relation to negative mood states, e.g., when feeling lonely, anxious, or depressed; and, the uncontrolled eating scale (9 items) assesses the tendency to lose control over eating when feeling hungry or when exposed to external stimuli
|
0,12 and 24 weeks
|
Body weight change
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on weight change
|
0, 8, 12 and 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Substrate oxidation
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on substrate oxidation (for example fat oxidation) and will be measured with ergo-spirometry tests
|
0, 8, 12 and 24 weeks
|
Hip circumference
Time Frame: 0, 8, 12 and 24 weeks
|
Exercise may have a positive effect on hip circumference and will be measured on the widest part of the hip in the horizontal plane.
|
0, 8, 12 and 24 weeks
|
Daily activity
Time Frame: 0, 17 and 24 weeks
|
Exercise can affect daily activity.
Measurements of 24-hour activity during free living will be performed with accelerometer (ActiGraph wGT3x-BT, Pensacola, FL, USA).
The 24-hour activity expressed as daily activity counts per minute (Vector magnitude, CPM).
The registrations will last for 24 hours during 7 days including the weekend.
|
0, 17 and 24 weeks
|
Total energy intake
Time Frame: 0 and 24 weeks
|
Exercise can affect total energy intake.
A 180 items food frequency questionnaire developed in Norway and validated to assess habitual diet among men and women, was will be used.
The dietary data will be entered by scanning, using the teleform program (10.0) (Datascan, Oslo, Norway).
Daily intake of foods, energy and nutrients will be calculated using software (KBS version 7.3 2017; developed at the institute of Basic Medical Sciences, University of Oslo).
The software is based on Norwegian food composition table (Norwegian Food Composition Database 2017.
Norwegian Food Safety Authority)
|
0 and 24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jøran Hjelmesæth, professor, The Hospital of Vestfold
Publications and helpful links
General Publications
- Berge J, Hjelmesaeth J, Kolotkin RL, Storen O, Bratland-Sanda S, Hertel JK, Gjevestad E, Smastuen MC, Helgerud J, Bernklev T. Effect of aerobic exercise intensity on health-related quality of life in severe obesity: a randomized controlled trial. Health Qual Life Outcomes. 2022 Feb 24;20(1):34. doi: 10.1186/s12955-022-01940-y.
- Berge J, Hjelmesaeth J, Hertel JK, Gjevestad E, Smastuen MC, Johnson LK, Martins C, Andersen E, Helgerud J, Storen O. Effect of Aerobic Exercise Intensity on Energy Expenditure and Weight Loss in Severe Obesity-A Randomized Controlled Trial. Obesity (Silver Spring). 2021 Feb;29(2):359-369. doi: 10.1002/oby.23078.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EGO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Training intensity intervention
-
Syracuse UniversityRecruitingCardiovascular Diseases | Obesity | Metabolic Disease | High-intensity Interval TrainingUnited States
-
Norwegian University of Science and TechnologyActive, not recruiting
-
Oakland UniversityCompletedHealthyUnited States
-
Aalborg University HospitalUniversity of Southern Denmark; TrygFonden, Denmark; Aalborg University; Steno... and other collaboratorsActive, not recruiting
-
Universiti Putra MalaysiaCompletedHealthy AgingMalaysia
-
Uppsala UniversityUppsala University Hospital; Uppsala County Council, SwedenCompleted
-
Universidade Federal do Rio de JaneiroCompleted
-
University of California, BerkeleyUniversity of San FranciscoCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...CompletedMetabolic and Inflammatory Variables Post Intervention | Composition and Function of the Gut Microbiota Post InterventionBrazil